当前位置:首页 - 行情中心 - 奇正藏药(002287) - 财务分析 - 现金流量表

奇正藏药

(002287)

  

流通市值:134.87亿  总市值:135.16亿
流通股本:5.30亿   总股本:5.31亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金727,120,533.532,245,453,250.871,480,860,322.67842,289,889.6
收到的税费返还-31,649,916.8331,659,549.1517,254,907.05
收到其他与经营活动有关的现金52,098,724.2383,619,609.0771,839,629.8959,905,300.98
经营活动现金流入的平衡项目0000
经营活动现金流入小计779,219,257.762,360,722,776.771,584,359,501.71919,450,097.63
购买商品、接受劳务支付的现金55,828,771.01161,577,820.5492,107,249.7154,683,221.96
支付给职工以及为职工支付的现金196,303,706.65532,909,660.22426,538,029.52300,181,701.12
支付的各项税费80,275,601.43364,994,444.8267,247,054.09186,170,333.19
支付其他与经营活动有关的现金190,992,629.72844,489,558.29567,250,482.89333,499,563.66
经营活动现金流出的平衡项目0000
经营活动现金流出小计523,400,708.811,903,971,483.851,353,142,816.21874,534,819.93
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额255,818,548.95456,751,292.92231,216,685.544,915,277.7
二、投资活动产生的现金流量:
收回投资收到的现金630,636,091.782,172,924,242.061,469,981,773.581,321,748,819.1
取得投资收益收到的现金18,954,392.671,205,335.5635,394,771.716,379,784.49
投资活动现金流入的平衡项目0000
投资活动现金流入小计649,590,484.382,244,129,577.621,505,376,545.281,338,128,603.59
购建固定资产、无形资产和其他长期资产支付的现金47,996,662.45255,443,057.03203,308,377.86193,664,360.93
投资支付的现金500,000,0002,506,703,904.111,625,703,904.11993,240,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计547,996,662.452,762,146,961.141,829,012,281.971,186,904,360.93
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额101,593,821.93-518,017,383.52-323,635,736.69151,224,242.66
三、筹资活动产生的现金流量:
取得借款收到的现金551,527,349.5811,872,650.5753,500,000653,500,000
收到其他与筹资活动有关的现金500,000---
筹资活动现金流入平衡项目0000
筹资活动现金流入小计552,027,349.5811,872,650.5753,500,000653,500,000
偿还债务支付的现金453,935,000660,487,821.43452,700,000352,700,000
分配股利、利润或偿付利息支付的现金118,543,220.13282,448,745.74279,584,500.168,826,764.45
支付其他与筹资活动有关的现金3,408,499.077,143,987.571,021,952.652,197,841.53
筹资活动现金流出平衡项目0000
筹资活动现金流出小计575,886,719.2950,080,554.74733,306,452.81363,724,605.98
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-23,859,369.7-138,207,904.2420,193,547.19289,775,394.02
四、汇率变动对现金及现金等价物的影响-54,508.06561,713.43-402,847.11230,788.62
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额333,498,493.12-198,912,281.41-72,628,351.11486,145,703
加:期初现金及现金等价物余额189,591,493.5388,503,774.91388,503,774.91388,503,774.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额523,089,986.62189,591,493.5315,875,423.8874,649,477.91
补充资料:
净利润-581,369,645.72-327,088,161.16
资产减值准备-1,179,197.47-87,996.89
固定资产和投资性房地产折旧-101,271,583.97-50,739,578.75
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-101,271,583.97-50,739,578.75
无形资产摊销-26,960,037.32-13,436,658.55
长期待摊费用摊销-1,028,041.55-514,020.77
固定资产报废损失-580,487.28-16,576.63
公允价值变动损失--105,137,133.35--53,145,146.88
财务费用-57,787,374.57-30,274,314.56
投资损失-4,821,968.32--4,982,971.34
递延所得税-8,705,415.72-12,729,888.85
其中:递延所得税资产减少-3,364,282.44-6,036,159.14
递延所得税负债增加-5,341,133.28-6,693,729.71
存货的减少--29,723,994.82--8,094,109.3
经营性应收项目的减少--278,789,064.9-671,542,129.79
经营性应付项目的增加-75,669,367.72--999,651,037.24
现金的期末余额-189,591,493.5-874,649,477.91
减:现金的期初余额-388,503,774.91-388,503,774.91
公告日期2025-04-252025-04-252024-10-302024-08-24
审计意见(境内)标准无保留意见
TOP↑